Hepatitis B virus (HBV) presents a higher residual risk of transmission by transfusion than
hepatitis C virus (HCV) or human immunodeficiency virus (HIV). While most infectious blood …

Hepatitis B virus (HBV) remains a major risk of transfusion-transmitted infection due to the
pre-seroconversion window period (WP), infection with immunovariant viruses, and with …

The article discusses hepatitis B virus (HBV) infection and transfusion medicine. It is said
that HBV, an obscure, hidden disease, is found in persons having HBV DNA in their blood or …

The detection of HBV DNA without HBsAg with or without the presence of HBV antibodies
outside the acute phase window period defines occult HBV infection. This condition has …

Hepatitis B virus (HBV) infection is endemic in many Asian countries. Among many
transmission routes, transfusion is the one that should be prevented. The first major success …

Evidence regarding the outcomes of viral super‐infection in patients with chronic liver
disease and practical strategies for hepatitis A and B vaccination of these individuals are …

Nucleic acid testing (NAT) for hepatitis B virus (HBV) has been performed in Poland since
2005 on samples seronegative for hepatitis B surface antigen (HBsAg), anti–hepatitis C …

Background Hepatitis is a viral infection of the liver. It is mainly transmitted between people
through contact with infected blood, frequently from mother to baby in‐utero. Hepatitis B …

As hepatites B e C continuam sendo um importante problema de saúde pública no Brasil.
Neste estudo, determinou-se a prevalência de marcadores sorológicos para as hepatites B …

More than 300 million people worldwide are infected with the hepatitis B virus (HBV), and
more than 1 million of them die each year of liver failure or hepatocellular carcinoma …